The life sciences industry’s must-attend conference catered to the unique legal and compliance challenges for specialty pharmaceutical companies focused on rare, ultra-rare and orphan diseases. Once again in collaboration with Biotech Week Boston, from emerging biotechs and recently commercialized companies to mid-size and large pharma, join the compliance community to discuss and prepare for the top risks and grey areas impacting specialty product manufacturers on a daily basis.
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
